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PURPOSE. Retinal ganglion cells (RGCs) are susceptible to mitochondrial deficits and also
the major cell type affected in patients with mutations in the OPA1 gene in autosomal
dominant optic atrophy (ADOA). Here, we characterized mitochondria in RGCs in vitro
from a heterozygous B6; C3-Opa1Q285STOP (Opa1+/−) mouse model to investigate mito-
chondrial changes underlying the pathology in ADOA.
METHODS. Mouse RGCs were purified from wild-type and Opa1+/− mouse retina by two-
step immunopanning. The mitochondria in neurites of RGCs were labeled with Mito-
Tracker Red for structure and motility measurement by time-lapse imaging. Mitochondrial
bioenergetics were determined by the real-time measurement of oxygen consumption
rate using a Seahorse XFe 96 Extracellular Flux Analyzer.
RESULTS. We observed a significant decrease in mitochondrial length in Opa1+/− RGCs
with a remarkably higher proportion and density of motile mitochondria along the
neurites. We also observed an increased transport velocity with a higher number of
contacts between mitochondria in Opa1+/− RGC neurites. The oxygen consumption
assays showed a severe impairment in basal respiration, Adenosine triphosphate-linked
(ATP-linked) oxygen consumption, as well as reserve respiratory capacity, in RGCs from
Opa1+/− mouse retina.
CONCLUSIONS. Opa1 deficiency leads to significant fragmentation of mitochondrial
morphology, activation of mitochondrial motility and impaired respiratory function in
RGCs from the B6; C3-Opa1Q285STOP mouse model. This highlights the significant alter-
ations in the intricate interplay between mitochondrial morphology, motility, and energy
production in RGCs with Opa1 deficiency long before the onset of clinical symptoms of
the pathology.
Keywords: autosomal dominant optic atrophy, retinal ganglion cells, OPA1,mitochondrial
motility, mitochondrial bioenergetics
Autosomal dominant optic atrophy (ADOA) is one of themost common autosomal inherited optic neuropathies.
It is characterized by a bilateral degeneration of the optic
nerves, causing a slowly progressive, insidious visual loss,
often beginning in childhood. There is irreversible pallor of
the optic disc, reduced thickness of the nerve fiber layer and
a ceco-central scotoma. The deficits are accompanied by a
tritanopic dyschromatopsia.1,2
The nuclear optic atrophy 1 gene (OPA1) is responsi-
ble for most (75%), cases of ADOA.3 Over 250 OPA1 muta-
tions have been reported in patients and a reduction in the
amount of OPA1 protein (haploinsufficiency) is believed to
be the major pathogenic mechanism in many ADOA cases.4,5
OPA1 is ubiquitously expressed and plays a crucial role in
the fusion process of inner mitochondrial membranes and in
the maintenance of the normal architecture of mitochondrial
cristae.3,6 It is also involved in the maintenance of oxida-
tive phosphorylation and membrane potential, as well as
the control of apoptosis through anchoring cytochrome c.
However, the cellular changes specific to retinal ganglion
cell (RGC), the predominant cell type affected in ADOA,7,8
caused by OPA1 deficiency before the onset of pathology
and their mechanisms remain unclear. Thus we hypothesize
that the alterations in mitochondrial dynamics during early
asymptomatic stages of ADOA precede the neurodegenera-
tion and consequent RGC cell death.
In our study, a heterozygous Opa1 mutant mouse model
(B6; C3-Opa1Q285STOP) was used to model the pathophys-
iology of ADOA disease in mice, which carry a protein-
truncating nonsense mutation in exon 8 immediately before
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the central dynamin-GTPase, leading to a ∼50% reduction
in Opa1 transcript and protein in retina and neural tissues.9
Here we provide a novel insight into the early changes in
the morphology, motility, and bioenergetics of mitochondria
in RGCs in early ADOA.
MATERIALS AND METHODS
Mouse Breeding
The heterozygous Opa1 mutation B6; C3-Opa1Q285STOP was
generated as previously described.9 The founder generation
mice were outcrossed to C57BL/6J (Charles River, UK) and
the experiments were performed on the mice bred from
generation 8 to 9. Mice were genotyped by Opa1 allele-
specific polymerase chain reaction.9 All animal procedures
were performed under license in accordance with the UK
Home Office Animals Scientific Procedures (Animals) Act
(1986) and the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research. The Cardiff University
Biological Standards Committee approved the experimen-
tal protocols. We followed the guidelines of the Animal
and Plant Health Agency for compliance with Regulation
(EC) 1069/2009 and implementing Regulation (EC) 142/2011
for the transport, storage, use, and disposal of animal by-
products.
RGC Culture
All procedures for RGCs culture were carried out on six- to
seven-day-old Opa1+/− and WT mouse pups using a two-
step immunopanning protocol from Winzeler and Wang10
with minor modifications. Briefly, the retina was dissected
out from the mouse eye and dissociated and triturated into
cell suspension. Afterward, cells were purified by two nega-
tive panning plates coated with Lectin from Bandeiraea
simplicifolia (BSL-1; Vector Laboratories Ltd., United King-
dom) to remove the contaminating cell types and RGCs were
finally selected by one positive panning plate coated with
Thy1.2 (CD90) IgM (Serotec MCA02R, Bio-Rad Laboratories,
Inc.) for 45 minutes at room temperature (25°C).
RGCs were collected and then seeded on glass cover-
slips (Academy Science Limited, UK) coated by Poly-D-lysine
(Sigma-Aldrich Corp., St. Louis, MO, USA) and laminin (R&D
Systems, Minneapolis, MN, USA) with a seeding density of
50,000 RGCs per well in 24-well culture plates (Nunc; Ther-
mofisher, Waltham, MA, USA). RGCs were cultured in a
humidified atmosphere at 37°C under 10% CO2, in serum-
free growth medium as previously described.10
The two-step immunopanning method can yield RGCs
with high purity (>80%) from rodents in published
research.11–14 In our lab, the purity of cultured RGCs was
identified by co-staining of anti-Thy 1.2 antibody and anti-
RBPMS antibody (Abcam).
Mitochondrial Morphology Assessment
Totally 65 WT mouse pups and 60 Opa1+/− mouse pups
were used for the three independent experiments. Purified
RGCs were extracted from approximately 20 WT or Opa1+/−
mouse pups in each panning procedure, plated in 24-well
plates in three replicates and then stained by the specific
mitochondrial marker, MitoTracker Red CMXRos (Molecular
Probes, Invitrogen) at 37°C for 30 min on the eighth day in
vitro. Images were captured under a oil magnification lens at
×63 using Zeiss LSM 880 confocal microscope and Zen Zeiss
software (Carl Zeiss, Oberkochen, Germany). The length of
each mitochondrial fragment was measured for morpholog-
ical assessment by FIJI software (v1.52p, Wayne Rasband,
National Institutes of Health, Bethesda, MD, USA).
Measurement and Classification of Mitochondrial
Motility
Time-lapse imaging was used to record mitochondrial
movements; images were captured every five seconds for
10 minutes from RGCs cultured from WT and Opa1+/−
mouse pups (n = 20 to 25 for each group) in three replicates
on the eighth day in vitro. Three independent experiments
were performed. Kymographs of mitochondrial movements
were generated by KymoAnlyzer15 plugin in FIJI software.
Depending on the kymographs generated from the
10-minute mitochondrial movement recordings, the mito-
chondria were classified as stationary (that moved no further
than 5 μm), or motile (moved further than 5 μm). The density
of mitochondria was calculated as the number of station-
ary or motile mitochondria per length of the neurite in μm.
The contact rate was calculated as the number of contacts
between mitochondrial tracks divided by the total number
of mitochondria per minute in each imaged region. The
velocities of movements were calculated for motile mito-
chondria from the generated kymographs: the length of
horizontal axis (the distance of movement) was divided by
the length of vertical axis (the time of movement lasted)
(μm/s).
Measurement of Mitochondrial Bioenergetics
The real-time measurement of oxygen consumption rate
(OCR) was carried out by the Seahorse XFe 96 Extra-
cellular Flux Analyzer (Agilent Technologies, Santa Clara,
CA, USA) using Seahorse XF Cell Mito Stress Test Kit
(no. 103015-100, Agilent Technologies) according to the
manufacturer’s protocol. Briefly, cells were plated at the
concentration of 20,000 cells/well in XFe 96 microplates
(Agilent Technologies) coated with Cell-Tak (no. 354240;
Corning, Corning, NY, USA). OCR was measured in Seahorse
XF DMEM Medium containing 10 mmol/L glucose, 1 mmol/L
pyruvate, and 2 mmol/L l-glutamine (no. 103575-100,
no. 103577-100, no. 103578-100, no. 103579-100, Agilent
Technologies) under basal conditions and in response to
three serial injected compounds—oligomycin (1.0 μmol/L),
carbonylcyanide-4-(trifluoro- methoxy) phenylhydrazone
(FCCP; 2.5 μmol/L), and a mixture of rotenone and antimycin
A (1.0 μmol/L) to determine the values for the basal mito-
chondrial respiration, Adenosine triphosphate-linked (ATP-
linked) oxygen consumption rate, maximal respiration, and
spare respiratory capacity. Each sample was plated in five
replicates. After the assays, the cells were immediately fixed
and stained with Hoechest 33342, and then the images of
whole well were captured by IX71 inverted microscope
(Olympus, Tokyo, Japan) to calculate the number of cells
in each well using FIJI software (v1.52p, Wayne Rasband,
National Institutes of Health). OCR values were normal-
ized to cell number. Three independent experiments were
performed.
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FIGURE 1. Identification of RGCs isolated by two-step immunopanning after two days in culture. (A) Phase-contrast image showing the
characteristic morphology of RGCs. (B) Immunofluorescent staining with Hoechst 33342 (blue), Thy1.2 (green), RBPMS (red), and the
merged image. Scale bar = 50 μm.
Statistical Analysis
The data are presented as means ± SEM. The data
were normally distributed and compared statistically
with unpaired Student’s t-test using GraphPad Prism
8.0 (GraphPad, San Diego, CA, USA). A value of P < 0.05
was defined as statistically significant.
RESULTS
Identification of Cultured RGCs
Approximately 23,000 to 27,000 RGCs were isolated
from each mouse retina by two-step immunopanning.
After two days in culture, RGCs were identified by
their plump rounded cell bodies with characteristic
long neurites (Fig. 1A). Cell identity was also veri-
fied histologically by immunofluorescent co-staining of
Thy1.2 and RBPMS (Fig. 1B). The purity was approxi-
mately 85.22%, calculated as the ratio of double-stained
Thy1.2 and RBPMS-positive cells to the total number
of cells within imaged regions from five independent
experiments.
Opa1 Deficiency Leads to Fragmented
Mitochondrial Morphology in Primary Mouse
RGCs
We measured the length of each mitochondrion along
the RGC neurites and documented the distribution of
mitochondrial length in μm using high-resolution confo-
cal microscopy (See Fig. 2A). The length of mitochondria
was 3.45 ± 0.20 μm in wild-type RGCs, whereas it was
1.92 ± 0.10 μm in Opa1+/− RGCs (decreased by
1.53 μm, P < 0.01, see Fig. 2B). Specifically, a
significantly higher proportion of mitochondria with
length < 1 μm (increased by ∼16.19%, P < 0.05), as
well as that of mitochondria with length between 1 and
2 μm (increased by ∼30.71%, P < 0.01) were observed in
Opa1+/− compared with the wild-type. However, there was
an obviously smaller proportion of mitochondria with length
between 3 and 4 μm (decreased by ∼21.64%, P < 0.01), as
well as that of mitochondria with length longer than 4 μm
(decreased by ∼18.26%, P < 0.05, see Fig. 2C). These results
show a concentrated distribution of mitochondrial length in
3 to 4 μm in the wild-type RGCs, whereas it is 1 to 2 μm in
Opa1+/− RGCs, indicating the fragmentation of mitochon-
dria, often caused by Opa1 deficiency.
Opa1 Deficiency Activates Mitochondrial Motility
in Primary Mouse RGCs
To investigate how Opa1 deficiency influences the mito-
chondrial movement within neurites of RGCs from
wild-type and Opa1+/− mice, time-lapse imaging of
live mitochondrial activity was performed. In total,
1280 mitochondria within 91 neurites from wild-type RGCs
and 1205 mitochondria within 92 neurites from Opa1+/−
RGCs were measured from three independent experiments.
As shown in Figure 3A, the movement of each mitochon-
drion has been manually tracked in kymographs generated
from the 10-minute time-lapse imaging.
In wild-type RGCs, 87.58% of mitochondria were station-
ary, and 12.42% of mitochondria moved further than 5
μm and were thus identified as motile. The distribution
of the mitochondrial population showed that there was a
significant increase in the proportion of motile mitochon-
dria in Opa1+/− RGCs compared with that in wild-type
RGCs (motile mitochondria increased by 10.53%, P < 0.05,
see Fig. 3B). Consistently, the density of motile mitochon-
dria per length of neurite in μm showed a marked increase
in Opa1+/− RGCs compared with the wild-type (P < 0.01,
see Fig. 3C).
Mitochondrial velocity is also an essential param-
eter of mitochondrial motility and dynamics; the
velocity of motile mitochondria was also measured
from kymographs. Remarkably, the motile mitochon-
dria in Opa1+/− RGC neurites presented an increased
velocity (0.39 ± 0.024 μm/s) compared with the wild-type
(0.24 ± 0.026 μm/s): the velocity was increased by approx-
imately 0.15 μm/s (P < 0.05, see Fig. 3D). Moreover, mito-
chondrial movements presented a concomitant increase in
contact rates between mitochondria in Opa1+/− RGCs (0.092
± 0.0070 contacts/mitochondrion/rate) compared with the
wild-type (0.050 ± 0.010 contacts/mitochondrion/rate,
P < 0.05, see Fig. 3E). These results suggest that mitochon-
dria in Opa1+/− RGCs display increased motility, with a
larger number of motile mitochondria, increased movement
velocity and a concomitant higher frequency of contacts in
response to the Opa1 deficiency.
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FIGURE 2. Opa1 deficiency results in decreased mitochondrial length in primary retinal ganglion cells (RGCs) fromOpa1+/− mouse compared
to wild-type. (A) The representative images with MitoTracker Red from wild-type and Opa1+/− RGCs cultures on the eighth day in vitro. (B)
The comparison of mitochondrial length in μm. (C) The distribution of mitochondrial length between wild-type and Opa1+/− RGCs. The
lengths of 658 mitochondria from wild-type RGC neurites and 812 mitochondria from Opa1+/− RGC neurites were calculated. The results
are shown as means ± SEM, from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. wild-type. Scale bar = 20 μm.
Opa1 Deficiency Leads to Impaired Mitochondrial
Bioenergetics in Primary Mouse RGCs
To explore how Opa1 deficiency in the B6; C3-Opa1Q285STOP
mouse influences mitochondrial bioenergetics in mouse
primary retinal ganglion cells, cellular OCRs were measured
in real time using the Seahorse XFe 96 Extracellular Flux
Analyzer with sequential injection of mitochondrial respi-
ration inhibitors. As shown in Figure 4B, Opa1 defi-
ciency caused a significant decline in the basal respira-
tion compared with the wild-type (P < 0.05) in the mouse
primary retinal ganglion cells. The first compound injected
in the assay was oligomycin, a complex V (ATP synthase)
inhibitor, used to clarify the proportion of ATP-linked
respiration in the basal respiration. The second injected
compound was FCCP, an uncoupling agent for collaps-
ing the proton gradient and disrupting the mitochondrial
membrane potential, used to determine the maximal respi-
ration. A combination treatment of antimycin A (complex
III inhibitor) and rotenone (complex I inhibitor) was finally
injected to shut down the whole mitochondrial respira-
tion. A significant decline was observed in ATP-linked respi-
ration, decreased by ∼21.16 pmol/min per 10,000 cells
(P < 0.05, see Fig. 4C), and maximal respiration, decreased
by ∼51.09 pmol/min per 10,000 cells (P < 0.05, see Fig. 4D),
respectively. Spare respiratory capacity, an indicator of cellu-
lar fitness which illustrates the capability of each cell to
respond to an energetic demand via oxidative phosphory-
lation is calculated by subtracting maximal OCR from the
basal OCR. The reserve capacity of mitochondrial respira-
tion was shown to be significantly lower in Opa1+/− retinal
ganglion cells compared with the wild-type (decreased by
∼28.65 pmol/min per 10,000 cells, P < 0.05, see Fig. 4E).
Overall, these results from the OCR assay showed that Opa1
deficiency caused lower basal respiration, decreased ATP-
linked oxygen consumption, diminished maximum value
of oxidative phosphorylation, and depletion of the cellular
capability for energy supply in mouse retinal ganglion cells.
DISCUSSION
ADOA is an inherited optic neuropathy characterized by
mitochondriopathy, which appears to result in selective RGC
degeneration in the retina, followed by ascending optic atro-
phy. The exquisite vulnerability of RGCs to mitochondrial
deficits caused by ADOA mutations may be associated with
the acute energy demand along the neurites combined with
their unique morphology.8 Here we demonstrate for the first
time that fragmented mitochondria caused by Opa1 defi-
ciency showed an actively increased motility along RGC
neurites in the presence of diminished mitochondrial bioen-
ergetic function in RGCs isolated from B6; C3-Opa1Q285STOP
mouse model.
Mitochondrial morphology is the result of a balance
between fusion and fission processes, and results in the
existence of small fragments or elongated tubular structures
based on the metabolic state of the cell. The defects in
Opa1 in our primary RGCs firstly caused fragmentation of
the tubular mitochondrial reticulum in RGCs, in which the
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FIGURE 3. Opa1 deficiency results in increased mitochondrial motility in primary retinal ganglion cells (RGCs) from Opa1+/− mouse
compared to wild-type. (A) Mitochondrial movement was visualized by MitoTracker Red and recorded by time-lapse imaging on the eighth
day in vitro. The movements were traced manually from automatically generated kymographs using FIJI software. Three key parameters of
mitochondrial motility were calculated: (B) distribution of the mitochondrion population classified as stationary and motile; (C) densities of
mitochondria calculated as the number of mitochondria per neurite length; (D) velocities of mitochondrial movement; (E) the contact rate
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calculated as the number of contacts between mitochondria divided by the total number of mitochondria per minute in each imaged region.
In total 1280 mitochondria, from 91 wild-type RGC neurites and 1205 mitochondria, from 92 Opa1+/− RGC neurites were measured. The
results are shown as means ± SEM, from three independent experiments. *P < 0.05, **P < 0.01 vs. wild-type. Scale bar = 20 μm.
FIGURE 4. Comparative analysis of mitochondrial bioenergetics between wild-type and Opa1+/− mouse primary retinal ganglion cells. Cells
were measured on the third day in vitro. (A) OCR profile plot. Oxygen consumption rate (OCR) was recorded by Seahorse Extracellular Flux
Analyzer at baseline and after the sequential injections of oligomycin (1 μmol/L), FCCP (2.5 μmol/L), and a mixture of rotenone and antimycin
(1 μmol/L). (B) Basal respiration, (C) ATP-linked respiration, (D) maximal respiration, (E) spare respiratory capacity was calculated. Data
are shown as the mean ± SEM of three independent experiments, each with five replicates. *P < 0.05 vs. wild-type group.
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lengths of mitochondria in Opa1+/− RGCs were decreased
to nearly half of that in the wild-type. These results are
consistent with the punctate pattern of mitochondria in
mouse embryonic fibroblasts (MEFs) from Opa1Q285STOP
mouse model,16 and in lymphoblastoid cell lines and fibrob-
lasts derived from ADOA patients.17–19 Mitochondria are
actively transported along microtubule tracks from the
soma to the RGC neurites, which is an energy-demanding
process in mammals.8 Interactions between polarized micro-
tubules, motor proteins, adaptors that link motor proteins to
mitochondria and anchors that arrest transport have been
demonstrated to trigger the motility of mitochondria.20 It
has also been reported that the activation of the energy
biosensor AMP-activated protein kinase (AMPK) contributes
to the detection of the energy deprivation in neurons which
contributes to the recruitment of mitochondria to the energy-
deficient area.21 The interplay in mitochondrial dynam-
ics, including the morphology, motility and fusion-fission
balance, are likely to be sophisticated and delicate. Previ-
ous studies demonstrated that augmented motility with a
higher number of mitochondria in the neighborhood could
increase the likelihood of contacts between individual mito-
chondrion, which was consequently associated with the
probability of fusion process. Furthermore, increased fusion
activity could then elongate the length of mitochondria in
turn probably activating the machinery of fission process
in order to inhibit a further elongation of mitochondrial
length.22,23 Additionally, it was shown that inhibited mito-
chondrial motility caused by nocodazol and vasopressin led
to suppressed merging frequency in H9c2 cells.24 In our
study, Opa1 deficiency caused shortened length of mito-
chondrial structures, an augmented number of motile mito-
chondria, with higher moving speed and was also accom-
panied by increased contact frequency between mitochon-
dria. It may be speculated that shortened mitochondria were
stimulated to increase motility in an attempt to increase the
possibility of fusion activity, which may be a response to
rescue the mitochondrial phenotype in RGCs suffering from
Opa1 deficiency.
Apart from the promotion of the fusion process, OPA1
also works as a master regulator of cristae structure and
remodeling, independently of its role in fusion.25,26 Since
cristae are critical to the machinery of mitochondrial oxida-
tive phosphorylation as the complexes of electron trans-
port chain are located within the large surface area of the
cristae, OPA1 therefore plays an essential role in regulat-
ing mitochondrial respiratory efficiency by directly changing
the control of cristae widening or constriction.27–29 Addition-
ally, elongated mitochondria also presented higher activity
of energy production because of the larger area of cristae,
higher levels of dimers of the ATPase as well as the escape
from autophagic degradation,30 emphasizing the vital char-
acter of OPA1 in modulating mitochondrial bioenergetics
and cell metabolism. However, the indicators of mitochon-
drial bioenergetics in samples from patients with ADOA
mutations has revealed some controversial and sometimes
conflicting results. Defective oxidative phosphorylation with
remarkably reduced mitochondrial adenosine triphosphate
production rate was observed in calf muscle in vivo from
six patients,31 consistent with the impaired ATP synthesis
driven by complex I substrates in skin fibroblasts derived
from ADOA patients,32 and the reduced oxygen consump-
tion as well as dysfunctional bioenergetics in lymphoblas-
toid cells obtained from four ADOA families.19 In contrast,
no alterations in mitochondrial oxidative phosphorylation
were observed in lymphoblastoid cells lines and fibrob-
lasts derived from patients,33 which were not associated
with the fragmented morphology.34 These conflicting results
may be due to the distinct effects of OPA1 mutations in
different cell types and might be associated with different
bioenergetic profiles seen with different OPA1 mutations.
Because the RGC is a cell type highly vulnerable to metabolic
disturbances and is exquisitely affected in patients with
ADOA, it is conceivable that the results of our mitochon-
drial measurements might be different in RGCs from other
cell types. According to our study, mitochondrial bioener-
getics in panned RGCs from the B6; C3-Opa1Q285STOP mouse
model revealed an impaired mitochondrial respiratory func-
tion with diminished reserve capacity in RGCs with Opa1
deficiency. Therefore, we propose, evidence that mitochon-
drial bioenergetics and energy production can be disrupted
in RGCs as a result of OPA1 deficiency.
The critical role of mitochondria is central not only in
ADOA but also another classical optic neuropathy—Leber
hereditary optic neuropathy—and even in some neurode-
generative diseases such as Alzheimer’s, Parkinson’s and
Huntington’s diseases in the central nervous system (CNS).35
In ADOA, in addition to the clinical visual loss caused
by the degeneration of optic nerves projected from about
1.2 million RGCs in the retina, some patients display a
“plus” phenotypes in a wider range of tissues including
CNS and brain, indicating a broader link between mito-
chondrial dysfunction caused by OPA1 deficit and neurode-
generation within the CNS.36 OPA1 exerts critical roles in
mitochondrial energy production through two independent
pathways. First, OPA1 protein directly affects cristae model-
ing by OPA1 to help regulate the mitochondrial energy
production through oxidative phosphorylation. OPA1 also
helps equilibrate the mitochondrial dynamic balance and
enhances the fusion process, so that the elongated mito-
chondria with a larger area of cristae are more likely to
consist of higher levels of dimers of the ATPase and escape
from autophagic degradation, which also enhances mito-
chondrial bioenergetics. Thus in ADOA, we speculated that
OPA1 deficit could cause impaired mitochondrial bioener-
getics through fragmentation of mitochondrial morphology
or direct damage of cristae structure. Surprisingly, with a
larger number of mitochondria detected in the neurites of
RGCs with higher motility, there would be higher probability
of mitochondrial contact. Because fusion activity could only
occur when two mitochondria meet, the higher contact rate
can then increase the possibility of fusion. Although only
less than 10% contacts could result in fusion reported in
cortical neurons,22 the mitochondria with increased contact
rates can also be benefit from mitochondrial “kiss-and-run”
interplays—transient fusions that could also be an alterna-
tive support for mitochondrial metabolism.24 In this path-
way the mitochondrial bioenergetics can be also promoted
consequently. Thus we infer that the activated motility
under OPA1 deficit in RGC neurites could be a spontaneous
compensation in an attempt to rescue the impaired fusion
and fission balance, as well as mitochondrial bioenergetics
(Fig. 5).
Previous research has demonstrated that about a third
of mitochondria are highly mobile before any branching
patterns in dendrites are established. Mitochondria become
largely stationary as they reach their positions at the
synapses and branch points where energy is needed in
mature RGC dendrites.37 Takihara et al.38 developed mini-
mally invasive intravital multiphoton imaging to record the
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FIGURE 5. Summarized hypothesis of the pathological mechanisms of ADOA and the spontaneous compensatory pathway through mito-
chondrial motility activation.
transportation of mitochondria in a single axon of RGCs in
vivo and illustrated the dynamics in axonal transport of mito-
chondria during aging as well as the disturbances of mito-
chondrial transport in a mouse glaucoma model. Previous
studies also demonstrated that mitochondria were promi-
nent in growth cones and preferentially recruited into distal
axons where actively extending through the AMP-activated
protein kinase (AMPK) energy-sensing pathway.39–41 Specif-
ically, Steketee et al.42 demonstrated the critical role of mito-
chondrial fission in normal growth cone dynamics and axon
extension by acutely inhibiting Drp1 function using mDivi-1
in rat retinal ganglion cell axons. Moreover, numerous intrin-
sic and extrinsic factors that regulate the axonal growth also
directly or indirectly effect the mitochondrial dynamics and
function such as BDNF,43 NGF,44 PTEN,45 and Nogo46,47 in
the CNS. Notably, Kreymerman et al.48 found a novel mito-
chondrial fission protein, MTP18, that could regulate the
mitochondrial size and also have a role in modulating neurite
outgrowth in RGCs during development and injury condi-
tions. Additionally, melanopsin-containing RGCs (mRGCs),
a special subset of RGCs constituting only 1% of the RGC
population in humans, were reported to be resistant to mito-
chondrial dysfunction and maintain the non-image-forming
light driven functions49,50 independently from melanopsin
expression.51 The large cellular size of mRGCs with a
high cellular content of mitochondria might be the possi-
ble factors protecting mRGCs from mitochondrial dysfunc-
tions.49,52 Unlike primary cortical neurons cultured in vitro
from fetal rodents which can establish synapse formation to
mature status resembling that in the cerebral cortex in vivo,53
purified RGCs cultured in vitro are unable to effectively
form synapses without soluble astrocyte-derived signals.54
Based on the findings in our current study from RGCs before
the completion of synaptogenesis, we hypothesize that the
increased motility of mitochondria could also possibly occur
in mature RGCs with OPA1 deficit compared to normal RGCs
in vivo. The generation of physiological relevant models,
such as differentiated RGCs from induced pluripotent stem
cells regenerated from patients’ somatic cells, may assist in
answering future questions.
Taken together, our results suggest that Opa1 haploin-
sufficiency leads to significant fragmentation of mitochon-
drial morphology, activation of mitochondrial motility and
impaired respiratory function in retinal ganglion cells from
the B6; C3-Opa1Q285STOP mouse model. The increased motil-
ity of mitochondria is hypothesized to be a spontaneous
compensatory response which promotes fusion activity and
facilitates energy production. More in-depth studies are
required to investigate the interplay between mitochon-
drial motility and bioenergetics and the precise mechanisms
underlying the stimulated mitochondrial motility caused by
Opa1 deficiency, which could be a new target for therapeutic
intervention.
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